Sun Pharmaceutical IndustriesNSE: SUNPHARMABSE: 524715Healthcare · PharmaceuticalsSun Pharmaceutical Industries Corporate Actions
Sun Pharmaceutical Industries has declared 1 bonus issue. The most recent was dated 29 Jul 2013.
- Bonus Issue
- 1
- Dividends
- 20
Sun Pharmaceutical Industries bonus issue history
Every bonus issue Sun Pharmaceutical Industries has declared, newest first.
| Ex Date | Type | Particulars |
|---|---|---|
| bonus | Bonus issue 1:1 |
Sun Pharmaceutical Industries dividends
Sun Pharmaceutical Industries has declared 20 dividends, most recently ₹5 per share with an ex-date of 07 Jul 2026.
How this is calculated
Corporate actions are sourced from company filings with NSE and BSE. Ex-date is the first day the stock trades without entitlement. Only actions the company has formally declared appear here.
Index membership reflects the Nifty 100 as published by NSE Indices, effective 2026-03-30.
Sun Pharmaceutical Industries: frequently asked questions
Has Sun Pharmaceutical Industries announced a bonus issue?
Sun Pharmaceutical Industries has declared 1 bonus issue, the most recent with an ex-date of 29 Jul 2013.
How many dividends has Sun Pharmaceutical Industries declared?
Sun Pharmaceutical Industries has 20 declared dividends on record, the latest being ₹5 per share with an ex-date of 07 Jul 2026.
What is a corporate action?
A corporate action is any company-initiated event that affects its shares — a dividend, bonus issue, stock split, rights issue, buyback or merger. Each one is declared to the exchanges with an ex-date.
What is the difference between a bonus issue and a stock split?
A bonus issue creates new shares out of reserves and hands them to existing holders free, so paid-up capital rises. A stock split subdivides existing shares into a smaller face value, leaving capital unchanged. Both increase the share count and reduce the price proportionally.
More Sun Pharmaceutical Industries data
Compare corporate actions with peers
Comparing corporate actions across companies is more useful than reading one in isolation — the peer links above open the same view for Sun Pharmaceutical Industries’s closest listed competitors.
The data, ratios and commentary about Sun Pharmaceutical Industries Ltd (SUNPHARMA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.